AIM Media House

AI Lifesciences

Latest AI Lifesciences news, analysis and insights from AIM Media House

The Hospital Ultrasound Revolution Has a Governance Problem

By Mukundan Sivaraj | March 12, 2026

Device fleets are manageable. Everything that determines whether clinicians can use them safely at scale is still being figured out

Veeva Acquires Ostro to Complete Its Pharma Commercial Stack

By Mukundan Sivaraj | March 11, 2026

The $100 million deal adds a patient- and physician-facing AI layer that Veeva's commercial software has never had

West Virginia's Biggest Health System Has a Staffing Crisis. AI Is Its Answer

By Mukundan Sivaraj | March 10, 2026

WVU Health System just deployed AI across every bed in its 25-hospital network. The state's nursing vacancy rate explains why

Caris Life Sciences Built an AI That Tells Oncologists to Back Off

By Mukundan Sivaraj | March 10, 2026

Oncology's default is always more. This tool says otherwise

CVS Spent $69 Billion Trying to Fix Healthcare. Now It's Trying Again

By Mukundan Sivaraj | March 7, 2026

A new AI platform built with Google Cloud promises the integration that $69 billion couldn't buy

Big Money Is Buying Up Radiology AI. Here's Why

By Mukundan Sivaraj | March 6, 2026

Hundreds of millions of dollars in deals are concentrating medical imaging's most important technology

Pfizer Adds AI Executive Layer as Tech Investments Mount

By Mukundan Sivaraj | March 5, 2026

The appointments come as Pfizer pursues a string of AI partnerships and projects $0.7 billion in manufacturing savings from AI

AI Can Translate for Hospital Patients. Should It?

By Mukundan Sivaraj | March 3, 2026

Hospitals are adopting AI translation faster than policymakers can validate it across hundreds of languages

Quest Diagnostics Launches Google Gemini Powered AI Companion

By Sachin Mohan | March 3, 2026

“People want to understand their lab data, but not everyone feels comfortable uploading their health data to public AI platforms”

Small Hospitals, Thin Margins, and a Bet on AI

By Mukundan Sivaraj | February 28, 2026

With hundreds of rural hospitals financially vulnerable, a growing number are deploying AI in screening and documentation

Every CT Scan Is Now A Heart Test

By Mukundan Sivaraj | February 23, 2026

A Michigan healthcare provider is Using AI for early heart disease detection

Ginkgo Bioworks’ Reshma Shetty on Moving Biology Off the Bench

By Mukundan Sivaraj | February 19, 2026

Autonomous infrastructure and AI agents change how experiments are designed and executed

Merck and Mayo Clinic Form Partnership for AI-Enabled Drug Discovery

By Sachin Mohan | February 19, 2026

“New cutting-edge technologies are enhancing our ability to innovate with the potential to bring important new therapies to patients faster”

AI Moves Into the EHR at Sutter Health

By Mukundan Sivaraj | February 17, 2026

The not-for-profit system integrates OpenEvidence into Epic after expanding AI across radiology and primary care

AxonDAO Leaves GPU Marketplaces Behind

By Mukundan Sivaraj | February 12, 2026

The decentralized science startup says it will run regulated AI workloads on Oracle Cloud Infrastructure

Spectral AI Appoints Finance Veteran Capone as CEO

By Sachin Mohan | February 11, 2026

With DeepView now under FDA review, Spectral AI has promoted Vincent S. Capone to CEO to drive the company’s transition from development to commercial execution.

Lunai Bioworks Launches AI Oncology Pilot to Analyze Phase 2 Colorectal Cancer Trial Data

By Sachin Mohan | February 10, 2026

"This collaboration reflects how AI can unlock hidden value in existing oncology datasets"

Nexalin Launches NeuroCare, An AI Virtual Clinic for Brain Health Disorders

By Sachin Mohan | February 6, 2026

"NeuroCare will remove mental health stigma, eliminate access barriers, and lower costs"

Palantir and Cognizant Launch Strategic AI Partnership

By Sachin Mohan | February 6, 2026

"This partnership reflects our commitment to using frontier technologies to deliver value for our clients, while also transforming our own businesses for the next era of AI-led growth"

Ginkgo Bioworks Turned Its Lab Over to GPT-5

By Mukundan Sivaraj | February 6, 2026

They claim that protein synthesis costs fell 40% after 36,000 automated experiments